留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

儿童传染性单核细胞增多症并发肺炎的影响因素分析及列线图模型的建立

杨幸幸 单鸣凤 孟慧

杨幸幸, 单鸣凤, 孟慧. 儿童传染性单核细胞增多症并发肺炎的影响因素分析及列线图模型的建立[J]. 中华全科医学, 2023, 21(12): 2077-2080. doi: 10.16766/j.cnki.issn.1674-4152.003294
引用本文: 杨幸幸, 单鸣凤, 孟慧. 儿童传染性单核细胞增多症并发肺炎的影响因素分析及列线图模型的建立[J]. 中华全科医学, 2023, 21(12): 2077-2080. doi: 10.16766/j.cnki.issn.1674-4152.003294
YANG Xingxing, SHAN Mingfeng, MENG Hui. Analysis of influencing factors and establishment of nomogram model for pneumonia complications in children with infectious mononucleosis[J]. Chinese Journal of General Practice, 2023, 21(12): 2077-2080. doi: 10.16766/j.cnki.issn.1674-4152.003294
Citation: YANG Xingxing, SHAN Mingfeng, MENG Hui. Analysis of influencing factors and establishment of nomogram model for pneumonia complications in children with infectious mononucleosis[J]. Chinese Journal of General Practice, 2023, 21(12): 2077-2080. doi: 10.16766/j.cnki.issn.1674-4152.003294

儿童传染性单核细胞增多症并发肺炎的影响因素分析及列线图模型的建立

doi: 10.16766/j.cnki.issn.1674-4152.003294
基金项目: 

南京医科大学一般性项目 NMUB2019191

江苏省卫生健康委2020年度医学科研立项项目 Z2020075

详细信息
    通讯作者:

    孟慧,E-mail:menghui@163.com

  • 中图分类号: R512.7 R725.6

Analysis of influencing factors and establishment of nomogram model for pneumonia complications in children with infectious mononucleosis

  • 摘要:   目的  构建预测儿童传染性单核细胞增多症(IM)并发肺炎的列线图模型,为儿童IM患者的肺炎筛查提供工具,并评价此模型的区分度与一致性。  方法  选取2020年1月—2022年1月南京医科大学附属儿童医院收治的272例IM儿童为研究对象,根据是否并发肺炎分为并发肺炎组与未并发肺炎组,比较并发肺炎组与未并发肺炎组的差异;采用logistic回归模型分析儿童IM患者并发肺炎的危险因素,根据所得危险因素采用R软件构建列线图预测模型。  结果  272例患儿并发肺炎40例,未发生肺炎232例,肺炎发生率为14.71%(40/272);与未并发肺炎组相比,并发肺炎组患儿热程、住院时间增长,脾大小增大,PCT、CRP水平升高(均P<0.05),预防性使用抗生素比例下降(P<0.05);二元logistic回归分析显示,热程长、脾大小增大是儿童IM患者发生肺炎的独立危险因素,预防性使用抗生素是儿童IM患者发生肺炎的保护因素。校准曲线显示斜率接近1。Hosmer-Lemeshow值显示χ2=8.022,P=0.431,提示构建的预测儿童IM患者肺炎发生的列线图模型一致性较好。  结论  儿童IM患者热程长短、脾大小、是否预防性使用抗生素因素是并发肺炎的影响因素,以此构建的列线图模型可用于预测IM患儿并发肺炎的风险程度。

     

  • 图  1  基于热程、脾大小、是否预防性使用抗生素因素构建的预测儿童IM患者肺炎发生列线图

    Figure  1.  The nomogram predicting pneumonia occurrence in children with IM based on heat duration, spleen size, and prophylactic antibiotic use

    图  2  ROC曲线评估儿童IM患者并发肺炎模型的区分度

    Figure  2.  ROC curve for the pneumonia differentiation model in children with IM

    图  3  儿童IM患者并发肺炎模型的校准曲线

    Figure  3.  Calibration curve for the pneumonia model in children with IM complications

    表  1  未并发肺炎组与并发肺炎组儿童IM患者一般资料比较

    Table  1.   Comparing general data between the pneumonia-free group and the pneumonia group

    项目 未并发肺炎组(n=232) 并发肺炎组(n=40) 统计量 P
    性别(例) 0.098a 0.754
      男 128 21
      女 104 19
    年龄(x±s,岁) 5.72±0.72 5.83±0.79 0.880b 0.380
    住院时间(x±s,d) 6.12±0.68 7.81±0.82 14.063b <0.001
    颈部淋巴结肿大(例) 1.117a 0.291
      有 167 32
      无 65 8
    眼睑水肿(例) 2.289a 0.130
      有 139 29
      无 93 11
    咽峡炎(例) 0.781a 0.377
      有 188 30
      无 44 10
    最高体温(例) 0.241c 0.810
      <37.3 ℃ 18 4
      37.3~38.5 ℃ 136 21
      >38.5 ℃ 78 15
    热程[M(P25, P75),d] 6.0(4.0,8.0) 8.0(5.0,11.5) 5.261c <0.001
    肝大小[M(P25, P75),cm] 2.2(1.3,3.4) 2.7(1.9,3.6) 1.136c 0.064
    脾大小[M(P25, P75),cm] 1.5(0.2,2.6) 2.2(1.5,3.5) 4.271c <0.001
    WBC[M(P25, P75),×109/L] 13.2(9.5,16.8) 18.3(9.3,20.5) 2.252c 0.052
    PBL[M(P25, P75),×109/L] 7.6(4.5,12.7) 8.2(5.8,12.5) 1.338c 0.172
    变异淋巴细胞比例[M(P25, P75), %] 0.1(0.0, 0.2) 0.1(0.0, 0.2) 1.734c 0.084
    PCT[M(P25, P75),μg/L] 0.05(0.01,0.10) 0.06(0.02,0.10) 2.224c 0.038
    CRP(x±s,mg/L) 3.46±0.35 4.26±0.44 12.824b <0.001
    LDH[M(P25, P75),U/L] 447.6(381.5,567.2) 495.1(372.8,572.4) 1.432c 0.125
    是否预防性使用抗生素(例) 23.466b <0.001
      是 131 6
      否 101 34
    注:a为χ2值,bt值,cZ值。
    下载: 导出CSV

    表  2  儿童IM患者并发肺炎的危险因素logistic回归分析

    Table  2.   Logistic regression analysis of risk factors for pneumonia in children with IM

    变量 B SE Wald χ2 P OR 95% CI
    住院时间 0.117 0.346 0.115 0.733 1.125 0.570~2.216
    热程 1.419 0.281 25.550 <0.001 4.134 2.384~7.167
    脾大小 1.320 0.491 7.239 0.007 3.744 1.431~9.793
    PCT 0.035 0.126 0.078 0.778 1.036 0.809~1.326
    CRP 0.332 0.221 2.259 0.132 1.394 0.903~2.149
    是否预防性使用抗生素 -1.728 0.580 89.892 0.003 0.178 0.057~0.553
    下载: 导出CSV
  • [1] LIU M, WANG X, ZHANG L, et al. Epidemiological characteristics and disease burden of infectious mononucleosis in hospitalized children in China: a nationwide retrospective study[J]. Virol Sin, 2022, 37(5): 637-645. doi: 10.1016/j.virs.2022.07.007
    [2] HU Z, ZHENG W, ZENG W, et al. Dynamically expressed miR-BART16 functions as a suppressor of CAND1 in infectious mononucleosis caused by epstein-barr virus in children[J]. Ann Clin Lab Sci, 2020, 50(3): 371-377.
    [3] 延融. EB病毒感染与巨细胞病毒感染的传染性单核细胞增多症患儿临床表现和实验室检查对比[J]. 基层医学论坛, 2021, 25(19): 2739-2740.

    YAN R. Comparison of clinical manifestation and laboratory examination between Epstein-Barr virus infection and cytomegalovirus infection in children with infectious mononucleosis[J]. The Medical Forum, 2021, 25(19): 2739-2740.
    [4] 姚艳青, 孔玮晶, 丁瑛雪, 等. 合并肺炎支原体感染的儿童EB病毒传染性单核细胞增多症的临床特点及高危因素分析[J]. 临床和实验医学杂志, 2021, 20(7): 762-766. doi: 10.3969/j.issn.1671-4695.2021.07.027

    YAO Y Q, KONG W J, DING Y X, et al. Clinical characteristics and risk factors of Epstein Barr virus infectious mononucleosis complicated with Mycoplasma pneumoniae infection in children[J]. Journal of Clinical and Experimental Medicine, 2021, 20(7): 762-766. doi: 10.3969/j.issn.1671-4695.2021.07.027
    [5] YANG D, GONG Z, YE C, et al. Positive correlation between VCA-IgM and Th1/Th2 immunocytokines in children with infectious mononucleosis[J]. Am J Transl Res, 2022, 14(10): 7578-7584.
    [6] 中华医学会儿科学分会感染学组, 全国儿童EB病毒感染协作组. 儿童主要非肿瘤性EB病毒感染相关疾病的诊断和治疗原则建议[J]. 中华儿科杂志, 2016, 54(8): 563-568.

    Infectiology Group of Pediatric Branch of Chinese Medical Association, National Children' s EB Virus Infection Cooperation Group. Recommendations for the diagnosis and treatment of major non-tumor Epstein-Barr virus infection-related diseases in children[J]. Chinese Journal of Pediatrics, 2016, 54(8): 563-568.
    [7] 赵亚凡. 不同病程阶段重症腺病毒肺炎患儿临床特征及胸部CT影像学征象分析[J]. 中国CT和MRI杂志, 2022, 20(8): 59-61.

    ZHAO Y F. Clinical features of children with severe adenovirus pneumonia at different stages and the imaging signs of chest CT[J]. Chinese Journal of CT and MRI, 2022, 20(8): 59-61.
    [8] EBELL M H, CALL M, SHINHOLSER J, et al. Does this patient have infectious mononucleosis? The rational clinical examination systematic review[J]. JAMA, 2016, 315(14): 1502-1509. doi: 10.1001/jama.2016.2111
    [9] CUI X, SNAPPER C. Epstein Barr virus: development of vaccines and immune cell therapy for EBV-Associated diseases[J]. Front Immunol, 2021, 12: 734471. DOI: 10.3389/fimmu.2021.734471.
    [10] 王丽琼. MP-DNA检测对儿童EB病毒相关传染性单核细胞增多症患者是否合并肺炎支原体感染的诊断价值分析[J]. 医药前沿, 2020, 10(15): 34-35.

    WANG L Q. Application of MP-PCR detection in the diagnosis of infectious mononucleosis with Mycoplasma pneumoniae infection in children[J]. Journal of Frontiers of Medicine, 2020, 10(15): 34-35.
    [11] 赖洁玉, 黎锦文, 李微, 等. EB病毒致传染性单核细胞增多症患儿并发肺炎的相关影响因素分析[J]. 现代医学与健康研究电子杂志, 2021, 5(23): 110-112.

    LAI J Y, LI J W, LI W, et al. Analysis of related influencing factors of pneumonia in children with infectious mononucleosis caused by Epstein-Barr virus[J]. Modern Medicine and Health Research Electronic Journal, 2021, 5(23): 110-112.
    [12] 胡岩岩, 潘家华, 周浩泉. 儿童传染性单核细胞增多症临床及实验室检查特点分析[J]. 中华全科医学, 2021, 19(9): 1510-1513. doi: 10.16766/j.cnki.issn.1674-4152.002099

    HU Y Y, PAN J H, ZHOU H Q. Analysis of clinical and laboratory characteristics of infectious mononucleosis in children[J]. Chinese Journal of General Practice, 2021, 19(9): 1510-1513. doi: 10.16766/j.cnki.issn.1674-4152.002099
    [13] 吕金晓. 参苏饮加减对急性上呼吸道感染伴发热儿童免疫功能及肺功能的影响[J]. 养生保健指南, 2021(27): 50.

    LYU J X. Effect of modified Shensuyin on immune function and lung function in children with acute upper respiratory tract infection and fever[J]. Health Guide, 2021(27): 50.
    [14] 何馨, 姚志刚, 符玉环, 等. EB病毒感染所致肺部感染患者的胸部高分辨CT特征分析[J]. 北京医学, 2022, 44(3): 236-240.

    HE X, YAO Z G, FU Y H, et al. Analysis of chest high resolution CT features in patients with pulmonary infection caused by Epstein-Barr virus infection[J]. Beijing Medical Journal, 2022, 44(3): 236-240.
    [15] 孙敏, 盛艳蕊, 周洪静. 成人传染性单核细胞增多症临床表现及实验室检查特点分析[J]. 中国药物与临床, 2020, 20(10): 1707-1708.

    SUN M, SHENG Y R, ZHOU H J. Analysis of clinical manifestations and laboratory characteristics of infectious mononucleosis in adults[J]. Chinese Remedies & Clinics, 2020, 20(10): 1707-1708.
  • 加载中
图(3) / 表(2)
计量
  • 文章访问数:  78
  • HTML全文浏览量:  26
  • PDF下载量:  7
  • 被引次数: 0
出版历程
  • 收稿日期:  2023-02-15

目录

    /

    返回文章
    返回